Robichaud Albert 4
4 · Sage Therapeutics, Inc. · Filed Feb 12, 2021
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-10+22,500→ 22,500 totalExercise: $82.27Exp: 2031-02-10→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The securities awarded on February 10, 2021 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,625 shares of common stock shall vest on the one year anniversary of February 10, 2021, with 16,875 shares vesting in 36 equal monthly installments thereafter.